Financings in Brief: Voxel
This article was originally published in The Gray Sheet
Voxel: Files registration statement with SEC for a proposed 2.3 mil. share public offering, net proceeds from which will be used to support "completion of development of the Digital Holography System, for expansion of marketing and sales activities for the system through 1997, to finance revenue growth and the accompanying increases in inventory and accounts receivable, and for general corporate purposes and working capital," the firm says. Laguna Hills, California-based Voxel received 510(k) clearance from FDA last fall for its Digital Holography system, which includes a camera, a light box, and film that interface with CT and MR scanners "to produce `three dimensional x-rays,'" the firm says. Cruttenden Roth Incorporated will underwrite the offering...
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.